PT3324938T - Formulações tópicas e tratamentos - Google Patents

Formulações tópicas e tratamentos

Info

Publication number
PT3324938T
PT3324938T PT168283828T PT16828382T PT3324938T PT 3324938 T PT3324938 T PT 3324938T PT 168283828 T PT168283828 T PT 168283828T PT 16828382 T PT16828382 T PT 16828382T PT 3324938 T PT3324938 T PT 3324938T
Authority
PT
Portugal
Prior art keywords
treatments
topical formulations
topical
formulations
Prior art date
Application number
PT168283828T
Other languages
English (en)
Original Assignee
Trilogic Pharma Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trilogic Pharma Llc filed Critical Trilogic Pharma Llc
Publication of PT3324938T publication Critical patent/PT3324938T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT168283828T 2015-07-20 2016-07-18 Formulações tópicas e tratamentos PT3324938T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562194518P 2015-07-20 2015-07-20

Publications (1)

Publication Number Publication Date
PT3324938T true PT3324938T (pt) 2021-09-21

Family

ID=57835134

Family Applications (1)

Application Number Title Priority Date Filing Date
PT168283828T PT3324938T (pt) 2015-07-20 2016-07-18 Formulações tópicas e tratamentos

Country Status (11)

Country Link
US (3) US11129896B2 (pt)
EP (1) EP3324938B1 (pt)
CA (3) CA2993012C (pt)
DK (1) DK3324938T3 (pt)
ES (1) ES2891754T3 (pt)
HU (1) HUE056401T2 (pt)
LT (1) LT3324938T (pt)
MX (2) MX390004B (pt)
PL (1) PL3324938T3 (pt)
PT (1) PT3324938T (pt)
WO (1) WO2017015232A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017015232A1 (en) 2015-07-20 2017-01-26 Trilogic Pharma Llc Topical formulations and treatments
WO2017137477A1 (en) 2016-02-09 2017-08-17 Bracco Suisse Sa A recombinant chimeric protein for selectins targeting
TW202310848A (zh) * 2021-07-26 2023-03-16 美商達雷生物科學公司 用於治療細菌性陰道病與其他適應症之系統及方法
AU2022319690A1 (en) * 2021-07-26 2024-03-14 Dare Bioscience, Inc. Compositions And Techniques For Vaginal Insertion
WO2024155777A2 (en) * 2023-01-19 2024-07-25 Dare Bioscience, Inc. Compositions and techniques for treatment of polycystic ovarian syndrome (pcos) and endometriosis
WO2024155775A2 (en) * 2023-01-19 2024-07-25 Dare Bioscience, Inc. Compositions and techniques for treatment of polycystic ovarian syndrome (pcos) and endometriosis
WO2024158951A2 (en) * 2023-01-25 2024-08-02 Dare Bioscience, Inc. Compositions and methods for treating dysmenorrhea

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6218023B1 (en) 1997-04-21 2001-04-17 Montell North America, Inc. Co-extruded laminate comprising at least one propylene graft copolymer layer
AU1223099A (en) * 1997-11-24 1999-06-15 Zhongming Zeng Pharmaceutical formulation for stimulating the growth of gram-positive bacil li and increasing the acidity in vagina and the use thereof
US20040167223A1 (en) 2002-09-03 2004-08-26 Popp Karl F. Topical antibacterial formulations
CN1311873C (zh) * 2004-06-30 2007-04-25 上海复康医药科技发展有限公司 一种温度敏感的阴道用原位凝胶制剂
US8501230B2 (en) 2007-12-03 2013-08-06 Trilogic Pharma Llc Self solidifying bioerodible barrier implant
EP2242476A2 (en) * 2008-01-14 2010-10-27 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US20100105750A1 (en) 2008-10-23 2010-04-29 Nycomed Us Inc. Stable metronidazole gel formulations
CN102525884A (zh) * 2010-12-19 2012-07-04 复旦大学 一种用于阴道给药的温敏原位凝胶制剂
CN111690204A (zh) 2011-08-31 2020-09-22 比瑞塑料公司 用于一种绝缘容器的聚合物材料
AU2013334155B2 (en) 2012-10-26 2017-02-02 Berry Plastics Corporation Polymeric material for an insulated container
WO2017015232A1 (en) 2015-07-20 2017-01-26 Trilogic Pharma Llc Topical formulations and treatments

Also Published As

Publication number Publication date
MX2018000800A (es) 2018-08-16
CA3209380A1 (en) 2017-01-26
HUE056401T2 (hu) 2022-02-28
US20250249105A1 (en) 2025-08-07
PL3324938T3 (pl) 2022-01-10
EP3324938A4 (en) 2019-03-13
EP3324938B1 (en) 2021-09-01
US11129896B2 (en) 2021-09-28
CA2993012A1 (en) 2017-01-26
CA2993012C (en) 2023-10-03
US12303563B2 (en) 2025-05-20
ES2891754T3 (es) 2022-01-31
EP3324938A1 (en) 2018-05-30
MX390004B (es) 2025-03-04
DK3324938T3 (da) 2021-09-27
CA3298548A1 (en) 2026-03-02
US20180207275A1 (en) 2018-07-26
WO2017015232A1 (en) 2017-01-26
LT3324938T (lt) 2021-11-25
MX2022001736A (es) 2022-03-11
US20220040306A1 (en) 2022-02-10

Similar Documents

Publication Publication Date Title
IL259570A (en) Combined therapy and their uses and methods
ZA201805805B (en) Formulations and methods
SG11201701292XA (en) Topical formulation
ZA201904704B (en) Topical cyclosporine-containing formulations and uses thereof
IL298438B2 (en) Medical combinations containing anti-FOLR1 immunoconjugates
EP3328353A4 (en) TOPICAL SKIN FORMULATIONS
PL3324938T3 (pl) Preparaty do stosowania miejscowego i sposoby leczenia
IL248934A0 (en) Topical formulations and their uses
ZA201802256B (en) Compounds and therapeutic uses thereof
IL268583A (en) Preparations and methods for use on the skin
SG11201706938XA (en) Topical formulation
EP3328354A4 (en) TOPICAL SKIN FORMULATIONS
EP3302530A4 (en) Cdh26 based therapeutic agents and their use
EP3273985A4 (en) Il-1ra based compositions and treatments
PT3373976T (pt) Formulações tópicas e suas utilizações
SG11201710686PA (en) Hair treatment agent
ZA201803987B (en) Topical skin care compositions comprising myrsine africana extracts
IL272945A (en) Local preparations and methods of treatment
GB201412976D0 (en) Hair treatments
GB2557383B (en) Hair treatments
EP3277249A4 (en) Keratin treatments
ZA201802201B (en) Novel formulation and treatment methods
GB201709850D0 (en) Hair treatments
GB2540931B (en) Improvements in or relating to beauty treatments
GB2545167B (en) Cloches and use thereof